N Freemantle, D Henry, A Maynard, G Torrance. Show Affiliations »
Abstract
Mesh: See more » AustraliaCanadaCost-Benefit AnalysisDrug CostsDrug IndustryDrug Prescriptions/economicsHumansUnited Kingdom
Year: 1995 PMID: 7728021 PMCID: PMC2549355 DOI: 10.1136/bmj.310.6985.955
Source DB: PubMed Journal: BMJ ISSN: 0959-8138